Analyst rates Insmed Incorporated a Strong Buy as Q3 BRINSUPRI sales reach $400.1 million and 2026 revenue guidance rises to ...
The following slide deck was published by CapitaLand Ascendas REIT in conjunction with this event.
Gold's wrapped up its largest weekly loss in eight months as the strong dollar, expectations of US interest rate increases ...
PHVS’s $2.25 billion valuation reflects commercial enthusiasm, but established treatments, emerging rivals and generic ...
Everforth is rated a Buy, with a $42 target at 7.38x eFY27 EV/aEBITDA; higher-margin consulting could benefit from AI, cyber, ...
Mercedes-Benz Group AG is rated a contrarian Buy, as 2026 car-margin guidance is about 3%, and each margin-point recovery ...
The iShares Global 100 ETF is upgraded to "Buy," viewing the global equity pullback as buyable despite no market all-clear.
Bath & Body Works is rated a Strong Buy, as $600 million in free cash flow implies a 16% yield, with a cautious DCF value of ...
AFOS is rated a Hold, as the ETF fell around 15% in three months, while its concentrated approach remains vulnerable despite GARP traits.
Analyst rates ARMOUR Residential REIT preferred shares ARR-C a Strong Buy at $17.12 on a 10.24% stripped yield; falling rates ...